Original

An assessment of the management of spasticity in Spain: the 5E Study

R. Garreta-Figuera, A. Torrequebrada-Giménez, en representación del Grupo de Estudio 5E [REV NEUROL 2016;63:289-296] PMID: 27658359 DOI: https://doi.org/10.33588/rn.6307.2016075

OPEN ACCESS

Volumen 63 | Number 07 | Nº of views of the article 9.586 | Nº of PDF downloads 862 | Article publication date 01/10/2016

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

INTRODUCTION Although spasticity is a disabling complication of high incidence, there is a lack of either regional or national epidemiological studies in Spain evaluating its management.

AIM To evaluate the management of spasticity in Spain.

PATIENTS AND METHODS An epidemiological, observational, multicenter, and retrospective study involving 49 rehabilitation services of public and private hospitals was designed.

RESULTS Two hundred and thirty-five patients from 49 centers, with evidence of upper (UL) or lower limb (LL) spasticity with one valid baseline visit and at least one follow-up visit, were included. Among the patients included in the study 148 (62.9%) have post stroke spasticity; 79 (33.6%) have LL spasticity, 38 (16.1%) UL, and 118 (50.3%) in both. At baseline, Modified Ashworth Scale, goniometry, Visual Analog Scale for pain and Tardieu Scale had been performed in 164 (69.8%), 99 (42.1%), 85 (36.2%), and 26 (11.1%) patients, respectively. A 93.8% (IC 95%: 81.4-97.6%) of the centers accurately defined the treatment goals and 52% of the objectives were agreed with the patient. Botulinum A toxin was administered in 186 (79.1%) of patients; 49 (20.9%) patients were treated with oral antispastic medications and 93 (39.6%) were under physiotherapy treatment.

CONCLUSIONS Most of the patients have post-stroke spasticity. Moreover, botulinum A toxin was the most commonly treatment applied to patients with spasticity. The results demonstrate that the management of spasticity varies significantly across the different centers participating in the study. KeywordsBotulinum A toxin Modified Ashworth Scale Spasticity Stroke Tardieu Scale CategoriesCalidad, Gestión y Organización Asistencial Patología vascular

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Original

An assessment of the management of spasticity in Spain: the 5E Study